How can a patient start on another antidepressant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Start a Patient on Another Antidepressant

When switching antidepressants, discontinue the current medication over 10-14 days to limit withdrawal symptoms, then initiate the new antidepressant using the starting dose and titrate upward every 5-7 days until therapeutic benefits or significant side effects appear. 1

Discontinuation Strategy for Current Antidepressant

  • Taper the current antidepressant over 10-14 days to minimize withdrawal symptoms, which is the standard approach recommended for all antidepressant discontinuations 1
  • Gradual tapering is particularly important for SSRIs and benzodiazepines to avoid withdrawal symptoms, and for antipsychotics and lithium to prevent rebound worsening of symptoms 1
  • The tapering schedule should account for the medication's half-life and receptor profile when transitioning between agents 1

Initiation of New Antidepressant

  • Start with the initial recommended dose of the new antidepressant rather than jumping to higher doses 1
  • Increase dosage using increments of the initial dose every 5-7 days until therapeutic benefits or significant side effects become apparent 1
  • This gradual titration approach prevents excessive dosing and reduces side effect burden 1

Timeline for Adequate Trial

  • A full therapeutic trial requires at least 4-8 weeks at an adequate dose before determining efficacy 1
  • Do not make premature medication changes, as this prevents adequate assessment of response 2
  • The actual antidepressant effects become apparent only after the first week or two of therapy 2

Selection of the New Antidepressant

Base selection on previous treatment response, tolerance, and the advantage of potential side effects (e.g., sedation versus activation) 1

For Patients with Insomnia:

  • Consider mirtazapine (starting 7.5 mg at bedtime, maximum 30 mg) as it promotes sleep, is potent and well-tolerated 1
  • Alternatively, trazodone (starting 25 mg daily, maximum 200-400 mg in divided doses) can be used 1
  • Nefazodone (starting 50 mg twice daily, maximum 150-300 mg twice daily) is effective especially with associated anxiety, though monitor for hepatotoxicity 1

For Patients with Apathy or Low Energy:

  • Consider bupropion (starting 37.5 mg every morning, maximum 150 mg twice daily) as it is activating and may produce rapid improvement in energy level 1
  • Give the second dose before 3 PM to minimize insomnia risk 1
  • Desipramine (starting 10-25 mg in morning, maximum 150 mg) tends to be activating and reduces apathy 1

For Patients with Agitated Depression:

  • Consider nortriptyline (starting 10 mg at bedtime, maximum 40 mg daily) as it is more sedating and useful in agitated depression with insomnia 1

Evidence for Second-Step Treatment Strategies

  • Switching to another antidepressant, switching to cognitive therapy, or augmenting with medication or cognitive therapy are all reasonable options with similar efficacy 1
  • The evidence supports that simply trying a different evidence-based approach is more important than the specific second-step strategy chosen 1
  • For augmentation strategies, buspirone or bupropion SR have moderate certainty evidence supporting similar efficacy to switching antidepressants 1

Common Pitfalls to Avoid

  • Do not use excessively high starting doses, as this does not hasten recovery and more often results in excessive doses and side effects 2
  • Do not assess efficacy before 4-8 weeks at therapeutic dose, as premature changes prevent adequate response assessment 1, 2
  • Do not abruptly discontinue the current antidepressant, as this increases withdrawal symptoms compared to gradual tapering 1
  • Do not assume all patients need indefinite treatment—after 9 months, dosage reduction can be used to reassess the need to medicate 1

Monitoring During Transition

  • Monitor closely for withdrawal symptoms during the taper period 1
  • Watch for emergence of depressive symptoms or new side effects with the new medication 1
  • Reassess response at 4-8 weeks to determine if the new antidepressant is providing therapeutic benefit 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initiating Antipsychotic Treatment in Acute Psychosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.